2Widemann P. Growth factor in retinal diseases [J]. Surv Ophthalmol Vis Sic 1992 ; 36 : 374.
3Ren G, Fuse N, Abe T,Tamai M. mRNA expression of protooncogenes and platelet-derived growth factor in proliferative vitreoretinal disease [J ]. Jpn J Ophthalmol 2000; 44 (3) : 308-311.
4The Reina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy[J]. Ophthalmology 1983, 90:121-125.
5Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ,Hunter T. Oncogene jun encodes a sequence-specific transactivator similar to AP-1[J]. Nature 1988; 332:166-171.
6Yasumasa O, Shoichi S, Hiroyuki M, Ichiro I, Masaya T, Yasuo T. Expression of c-fos and c-jun mRNA following transient retinal ischemia : an approach using ligation of the retinal central artery in the rat [J ]. Surv Ophthalmol 1997 ,42 (Suppl 1 ) : 96-104.
7Campochiaro PA. Pathogenic mechanisms in proliferative vitreoretinopathy[J]. Arch Ophthalmol 1997,115:237-241.
8El-Ghrably IA, Dua HS, Orr Gu, Fischer D, Tighe PJ. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy [J]. Br J Ophthalmol 2001, 85: 461-470.
9Hackett SF, Conway BP, Campochiaro PA. Subretinal fluid stimulation of retinal pigment epithelial cell migration and proliferation is dependent on certain features of the detachment or its treatment[J]. Arch Ophthalmol 1989,107:91.
